Federal agencies, including the Energy Department, EPA, and NOAA, announced they are rehiring probationary employees who were recently laid off. These workers are not being reinstated to active duties but placed on paid administrative leave while ongoing lawsuits move through the courts. While some employees now have temporary income restored, the uncertainty surrounding their future
Abuse of authority can happen in many different settings. It may involve misconduct by an employer, a government agency, law enforcement, or another person in a position of power. Whatever the specifics, your Washington, D.C. civil rights lawyer can help you get the justice you deserve. At Eric Siegel Law, we’ve been righting wrongs for
Contracts form the foundation of many business relationships. But when one side does not live up to the agreement, you may need to contact your Silver Spring, MD business litigation lawyer. Whether it is a missed payment, delayed delivery, or a complete failure to perform, the team at Eric Siegel Law is ready to use
Losing a job is always difficult, but being fired unfairly makes it even harder. Fortunately, your Washington, D.C. employment litigation lawyer can help. At Eric Siegel Law, we’ve been helping our clients for over 30 years. Now, we’re ready to use our experience to help you. Read on to learn more about unfair firings, and
Rent disputes are a common challenge in property management, but they sometimes involve more than just financial disagreements. Unfortunately, many renters civil rights’ are violated when landlords discriminate against, harass, or demonstrate unequal treatment towards them. But thankfully this is illegal and renters who are discriminated against can get legal help to protect their rights.
BioNTech has announced a significant restructure of its Gaithersburg, Maryland cell therapy operations, resulting in the layoff of 63 employees by the end of 2025. This move follows disappointing Phase I clinical trial results for its CAR-T candidate BNT211 targeting testicular cancer and germ cell tumors. Consequently, the company will wind down all cell therapy